References
- Kelly JP, Cook SF, Kaufman DW, Anderson T, Rosenberg L, Mitchell AA. Prevalence and characteristics of opioid use in the US adult population. Pain. 2008;138(3):507–513. Epub 2008 Mar 14. doi:10.1016/j.pain.2008.01.02718342447
- U.S. Food and Drug Administration. [homepage on the Internet]. Questions and Answers on FDA’s Adverse Event Reporting System (FAERS). What is FAERS? 2018 6 4 Available from: https://www.fda.gov/drugs/surveillance/fda-adverse-event-reporting-system-faers. Accessed August 9, 2019.
- Marks NS MedWatch: safety information and adverse event reporting. 7 11, 2017 Available from: http://www.medscape.org/viewarticle/588757. Accessed 510, 2019.
- Poluzzi E, Raschi E, Piccinni C, de Ponti F. Data mining techniques in pharmacovigilance: analysis of the publicly accessible FDA Adverse Event Reporting System (AERS) In: Karahoca A, editor. Data Mining Applications in Engineering and Medicine. Croatia: InTech; 2012:267–301.
- Stat Trek. Statistics dictionary. Frequency Count; 2019 Available from: http://stattrek.com/statistics/dictionary.aspx?definition=frequency%20count. Accessed 510, 2019.
- Reid A. Advantages & disadvantages of a frequency table. Sciencing. 2018 Available from: https://sciencing.com/advantages-disadvantages-frequency-table-12000027.html. Accessed May 10, 2019.
- Veronin MA, Schumaker RP, Dixit R, Dhake P, Ogwo M. A systematic approach to “cleaning” of drug name records data in the FAERS database. IJBDM. In press 2019.
- National Institute on Drug Abuse. DrugFacts. Prescription opioids. 6 2018 Available from: https://www.drugabuse.gov/publications/drugfacts/prescription-opioids. Accessed 510, 2019.
- Miller SC. Dextromethorphan psychosis, dependence and physical withdrawal. Addict Biol. 2005;10(4):325–327. doi:10.1080/1355621050035241016318953
- Yokell MA, Zaller ND, Green TC, Rich JD. Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review. Curr Drug Abuse Rev. 2011;4(1):28–41. doi:10.2174/187447371110401002821466501
- Tutorialspoint. MySQL - Select Query: 2019 Available from: https://www.tutorialspoint.com/mysql/mysql-select-query.htm. Accessed 510, 2019.
- Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: a clinician’s guide to terminology, documentation, and reporting. Ann Intern Med. 2004;140:795–801. doi:10.7326/0003-4819-140-10-200405180-0000915148066
- Institute for Healthcare Improvement. Measures. Adverse events per 1,000 doses; 2019 Available from: http://www.ihi.org/resources/Pages/Measures/ADEsper1000Doses.aspx. Accessed 510, 2019.
- Carlberg C. Statistical analysis with microsoft excel 2013: about variables and values. Informit. 5 20, 2014 Available from: http://www.informit.com/articles/article.aspx?p=2201796&seqNum=3. Accessed 510, 2019.
- Cone EJ, Fant RV, Rohay JM, et al. Oxycodone involvement in drug abuse deaths: a DAWN-based classification scheme applied to an oxycodone postmortem database containing over 1000 cases. J Anal Toxicol. 2003;27(2):57–67. doi:10.1093/jat/27.2.5712669998
- Consumer Products Healthcare Association. Dextromethorphan: preventing teen cough medicine abuse 2019 Available from: https://www.chpa.org/dex.aspx. Accessed 510, 2019.
- Bershidsky L Supply, not despair, caused the opioid epidemic. Bloomberg. 1 10, 2018 Available from: https://www.bloomberg.com/opinion/articles/2018-01-10/supply-not-despair-caused-the-opioid-epidemic. Accessed 510, 2019.
- National Institute on Drug Abuse. Opioid overdose crisis. 1 2019 Available from: https://www.drugabuse.gov/drugs-abuse/opioids/opioid-overdose-crisis. Accessed 74, 2019.
- Liu L, Pei DN, Soto P. History of the opioid epidemic. How did we get here? Poison Control. National Capital Poison Center. 2019 Available from: https://www.poison.org/articles/opioid-epidemic-history-and-prescribing-patterns-182. Accessed 74, 2019.
- Overstreet B A closer look at FDA’s adverse event reporting system. Patient Safety & Quality Healthcare. 1 24, 2012 Available from: https://www.psqh.com/analysis/a-closer-look-at-fdas-adverse-event-reporting-system/. Accessed 510, 2019.
- Stergiopoulos S, Brown CA, Felix T, Grampp G, Getz KA. A survey of adverse event reporting practices among US healthcare professionals. Drug Saf. 2016;39(11):1117–1127. doi:10.1007/s40264-016-0455-427638657
- Committee on the Assessment of the U.S. Drug Safety System, Baciu A, Stratton K, Burke SP, editors. The Future of Drug Safety: Promoting and Protecting the Health of the Public. Washington (DC): National Academies Press; 2006:Ch2:20.
- Pal S. Reporting and consequences of adverse events. US Pharm. 2017;42(10):12.
- Sakaeda T, Tamon A, Kadoyama K, Okuno Y. Data mining of the public version of the FDA adverse event reporting system. Int J Med Sci. 2013;10(7):796–803. doi:10.7150/ijms.604823794943